Showing results (451-460 of 1,214) with videos related to

Sort By:
Pageof 122
ACS Applied Bio Materials|October 12, 2022
Point-of-Care Biosensing of Urinary Tract Infections Employing Optoplasmonic Surfaces Embedded with Metal NanotwinsMitali Basak, Shirsendu Mitra, Mousumi Gogoi, et al.
American Journal of Otolaryngology|August 29, 2022
Clinical practice guidelines for management of medullary thyroid carcinoma: An AGREE II appraisalChristian Fritz, Emma De Ravin, Neeraj Suresh, et al.
Neuroendocrinology|September 27, 2008
Thyroid hormone homeostasis in brain: possible involvement of adrenergic phenomenon in adult ratSamita Kundu, Angshuman Biswas, Sumedha Roy, et al.
Small (Weinheim an Der Bergstrasse, Germany)|June 2, 2025
Nanoparticle Therapeutics in Clinical Perspective: Classification, Marketed Products, and Regulatory LandscapeNimeet Desai, Dhwani Rana, Mitali Patel, et al.
Biorxiv : the Preprint Server for Biology|July 16, 2025
PUM2 binds SARS-CoV-2 RNA and PUM1 mildly reduces viral RNA levels, but neither protein affects progeny virus productionNhi Phan, Yelizaveta Zaytseva, Chia-Ching Lin, et al.
Ocular Immunology and Inflammation|October 30, 2025
Refractory Bacterial Keratitis: Risk Factors and OutcomeMitali Vijay Mangoli, Smruti Rekha Priyadarshini, Srikant Kumar Sahu, et al.
Roczniki Panstwowego Zakladu Higieny|March 9, 2016
Association of occupational stress factors on nicotine dependence among patients visiting dental care unit of Indo-Tibetian border police force station in IndiaKarandeep Singh Sandhu, Vikram Arora, Nidhi Gupta, et al.
Journal of Clinical and Experimental Dentistry|February 9, 2016
Effectiveness of oral health education versus nicotine replacement therapy for tobacco cessation- a parallel randomized clinical trialMitali Raja, Sabyasachi Saha, Vamsi Krishna-Reddy, et al.
In Silico Pharmacology|April 18, 2022
Computational approaches for the design of novel dopamine D2 and serotonin 5-HT2A receptor dual antagonist towards schizophreniaAkash Rathore, Vivek Asati, Mitali Mishra, et al.
Pharmaceutics|September 28, 2021
Inhibition of Scavenger Receptor Class B Type 1 (SR-B1) Expression and Activity as a Potential Novel Target to Disrupt Cholesterol Availability in Castration-Resistant Prostate CancerMitali Pandey, Grace Cuddihy, Jacob A Gordon, et al.
Pageof 122